In addition, both DGAT1 and DGAT2 were upregulated in 179 pancreatic cancer tissues compared to 171 normal pancreatic tissues; however, pancreatic cancer patients with high or low expressions of DGAT1 or DGAT2showed no significant difference in overall survival after five years follow-up [119]. This evidence concerns the gene DGAT2 and familial pancreatic carcinoma.